Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,345 | 382 | 99.8% |
| Education | $8.71 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,048 | 71 | $0 (2024) |
| ABBVIE INC. | $903.90 | 59 | $0 (2024) |
| PFIZER INC. | $668.92 | 93 | $0 (2024) |
| GlaxoSmithKline, LLC. | $483.83 | 29 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $414.02 | 34 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $302.77 | 20 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $276.10 | 10 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $200.55 | 7 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $144.66 | 3 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $111.72 | 9 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $325.39 | 20 | ABBVIE INC. ($78.96) |
| 2023 | $803.65 | 51 | AbbVie Inc. ($275.08) |
| 2022 | $872.72 | 53 | ABBVIE INC. ($376.49) |
| 2021 | $610.93 | 44 | AbbVie Inc. ($173.37) |
| 2020 | $242.58 | 12 | Novo Nordisk Inc ($130.27) |
| 2019 | $329.50 | 47 | Novo Nordisk Inc ($152.38) |
| 2018 | $812.96 | 59 | Novo Nordisk Inc ($210.24) |
| 2017 | $1,356 | 98 | Janssen Pharmaceuticals, Inc ($262.56) |
All Payment Transactions
384 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $16.43 | General |
| Category: Heart Failure and Hypertension | ||||||
| 08/27/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Respiratory | ||||||
| 07/25/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Diabetes | ||||||
| 06/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.19 | General |
| Category: Cardiovascular | ||||||
| 04/16/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Cardiology | ||||||
| 03/14/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: ANTI-ANXIETY | ||||||
| 03/13/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Diabetes | ||||||
| 02/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: NEUROSCIENCE | ||||||
| 01/08/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/29/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX, AREXVY | Food and Beverage | In-kind items and services | $5.92 | General |
| Category: RESPIRATORY | ||||||
| 12/20/2023 | AbbVie Inc. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $2.60 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2023 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: ANTI-ANXIETY | ||||||
| 12/12/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 764 | 1,924 | $249,704 | $112,140 |
| 2022 | 30 | 1,957 | 3,633 | $307,571 | $150,841 |
| 2021 | 39 | 2,722 | 6,247 | $385,563 | $196,050 |
| 2020 | 42 | 2,699 | 6,460 | $362,500 | $165,725 |
All Medicare Procedures & Services
124 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 268 | 941 | $94,100 | $41,259 | 43.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 189 | 467 | $65,380 | $27,391 | 41.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 60 | 206 | $36,050 | $17,397 | 48.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2023 | 118 | 118 | $20,650 | $13,772 | 66.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 54 | 78 | $19,890 | $5,582 | 28.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 27 | 34 | $4,080 | $2,005 | 49.1% |
| 99496 | Transitional care management services for problem of high complexity | Facility | 2023 | 13 | 13 | $2,860 | $1,820 | 63.6% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 12 | 44 | $3,300 | $1,270 | 38.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Facility | 2023 | 12 | 12 | $2,580 | $1,233 | 47.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Facility | 2023 | 11 | 11 | $814.00 | $410.96 | 50.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 263 | 801 | $82,469 | $42,054 | 51.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 183 | 340 | $52,335 | $24,640 | 47.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 125 | 223 | $31,220 | $15,622 | 50.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 166 | 258 | $25,800 | $12,477 | 48.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 61 | 153 | $24,861 | $11,457 | 46.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2022 | 68 | 68 | $11,900 | $8,061 | 67.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 48 | 48 | $8,955 | $5,735 | 64.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 50 | 79 | $18,017 | $4,530 | 25.1% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 25 | 28 | $5,885 | $4,200 | 71.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 27 | 70 | $7,966 | $3,669 | 46.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 40 | 55 | $6,180 | $2,895 | 46.8% |
| 90662 | Influenza vaccine split virus, preservative free | Facility | 2022 | 44 | 44 | $2,904 | $2,846 | 98.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 35 | 41 | $2,665 | $1,819 | 68.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 83 | 102 | $2,550 | $1,359 | 53.3% |
| G0008 | Administration of influenza virus vaccine | Facility | 2022 | 43 | 43 | $1,665 | $1,130 | 67.9% |
About Dr. Willard Burks, M.D
Dr. Willard Burks, M.D is a Family Medicine healthcare provider based in Wynne, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619082310.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Willard Burks, M.D has received a total of $5,354 in payments from pharmaceutical and medical device companies, with $325.39 received in 2024. These payments were reported across 384 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($5,345).
As a Medicare-enrolled provider, Burks has provided services to 8,142 Medicare beneficiaries, totaling 18,264 services with total Medicare billing of $624,755. Data is available for 4 years (2020–2023), covering 124 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Wynne, AR
- Active Since 08/20/2006
- Last Updated 03/29/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1619082310
Products in Payments
- UBRELVY (Drug) $478.27
- Ozempic (Drug) $439.39
- QULIPTA (Drug) $357.07
- TRELEGY ELLIPTA (Drug) $332.73
- ELIQUIS (Drug) $317.86
- FARXIGA (Drug) $200.74
- CHANTIX (Drug) $195.85
- XARELTO (Drug) $189.93
- Victoza (Drug) $176.00
- Tresiba (Drug) $171.35
- JARDIANCE (Drug) $168.52
- GEMTESA (Drug) $158.89
- ENTRESTO (Drug) $144.66
- RYBELSUS (Drug) $142.74
- AREXVY (Drug) $123.75
- INVOKANA (Drug) $112.84
- Ranexa (Drug) $100.00
- LYRICA (Drug) $97.15
- Utibron (Drug) $95.50
- PREVNAR - 13 (Biological) $94.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Wynne
Dr. Mark Bradshaw, M.d, M.D
Family Medicine — Payments: $5,627
Dr. James Cathey, M.d, M.D
Family Medicine — Payments: $4,594
Dr. James Beaton, M.d, M.D
Family Medicine — Payments: $3,374
Sean Koch, Md, MD
Family Medicine — Payments: $3,138
Jeremiah Nugent, M.d, M.D
Family Medicine — Payments: $2,336
Mrs. Lesli Anderson, Aprn, APRN
Family Medicine — Payments: $390.90